Related Experiment Video
Updated: Aug 10, 2026

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
Living paid organ transplantation results in unacceptably high recipient morbidity and mortality
N G Inston1, D Gill, A Al-Hakim
1Department of Nephrology and Renal Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Insights
Payment for living unrelated kidney donors leads to high mortality and graft loss. This audit highlights the unacceptable risks and poor outcomes associated with organ trading, urging caution for desperate patients.
Area of Science:
- Nephrology
- Transplantation Surgery
- Medical Ethics
Background:
- The ethical debate on compensating living unrelated kidney donors persists with limited outcome data.
- High demand for renal replacement therapy in certain populations leads some patients to seek transplants abroad.
- Patients often travel abroad against medical advice for unrelated donor kidney transplants due to limited domestic options.
Purpose of the Study:
- To audit the outcomes of patients undergoing unrelated donor kidney transplants.
- To assess the scale of the problem of patients seeking transplants abroad.
- To evaluate the risks and success rates associated with these procedures.
Main Methods:
- A national audit was conducted within the UK.
- Identification of patients who received unrelated donor kidney transplants abroad.
- Review of transplant outcomes, including mortality and graft survival.
Main Results:
- A total of 23 patients were identified, all having traveled abroad against medical advice.
- High mortality (35%) and graft loss (56%) were observed in this cohort.
- Inadequate information was provided from transplanting centers in all cases, suggesting an underestimate of the issue.
Conclusions:
- Organ trading is associated with unacceptable risks and poor patient outcomes.
- Transplants based on monetary rather than clinical criteria lead to exploitation.
- The practice of paying for organs cannot be endorsed due to significant risks to both donors and recipients.
Abstract:
The ethical debate surrounding the payment of living unrelated donors continues despite very little evidence regarding the outcome. The aim of this audit was to identify the scale of the problem and assess the results of patients undergoing these procedures. The large Indo-Asian population within our region has a high demand for renal replacement therapy and transplantation. These patients have a limited chance of receiving a transplant for several reasons and some resort to traveling abroad, against medical advice, to procure an unrelated donor kidney transplant. Following an initial audit in our region, a national audit was conducted within the UK. A total of 23 patients were identified, all of whom had done so against medical advice. Mortality from causes directly related to transplantation was high in this group (35%), as was graft loss. The overall rate of successful transplants was only 44% (overall graft loss was 56%) in the short term. The information regarding both donor and recipient, provided from the transplanting center, was inadequate in all cases. These results, which almost certainly represent an underestimate of an ongoing situation, reinforce the standpoint that organ trading is associated with unacceptable risks and poor outcomes. The basis of this trade in organs is based on monetary rather than clinical criteria and such exploitation of both donor and recipient lead us to conclude that this practice cannot be endorsed and even the most desperate dialysis patients should be reminded of the unacceptable risks involved in this practice.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

